Evidence map›Paper›PMID 34780266›Full record

ArticleAntimicrobial agents and chemotherapy2022

Decreased Methylenetetrahydrofolate Reductase Activity Leads to Increased Sensitivity to

Ji-Fang Yu, Jin-Tian Xu, Shan-Shan Yang, Mei-Na Gao, Hao-Rui Si, Dong-Yan Xiong, Jing Gu, Zhi-Long Wu, Jie Zhou, Jiao-Yu Deng

Open access · hybridAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Mutations inJAC-antimicrobial resistance · 2026
    Article
  2. Article
  3. Article
  4. The T120P or M172V mutation onEmerging microbes & infections · 2024
    Article
  5. Mutational and structural studies of (βα)Protein science : a publication of the Protein Society · 2024
    Article
  6. Article
  7. Competition between HAntibiotics (Basel, Switzerland) · 2023
    Article
  8. Association between mutations in aEmerging microbes & infections · 2023
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Ji-Fang Yu *Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, People's Republic of China.ORCID 0000-0003-2446-6975
Jin-Tian Xu *Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, People's Republic of China.ORCID 0000-0001-9847-1617
Shan-Shan YangKey Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, People's Republic of China.
Mei-Na GaoSchool of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, People's Republic of China.
Hao-Rui SiKey Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, People's Republic of China.
Dong-Yan XiongKey Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, People's Republic of China.
Jing GuKey Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, People's Republic of China.
Zhi-Long WuFoshan Fourth People's Hospital, Foshan, People's Republic of China.
Jie ZhouFoshan Fourth People's Hospital, Foshan, People's Republic of China.
Jiao-Yu DengKey Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, People's Republic of China.ORCID 0000-0003-1819-2875
Chinese Academy of Sciences · CNNanjing University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculosis (TB), caused by Mycobacterium tuberculosis, is one of the most fatal diseases in the world. Methylenetetrahydrofolate reductase (MTHFR) catalyzes the production of 5-methyltetrahydrofolate (5-CH

Indexed as

Aminosalicylic AcidMycobacterium tuberculosisAntitubercular AgentsBacterial ProteinsMethylenetetrahydrofolate Reductase (NADPH2)Microbial Sensitivity TestsAminosalicylic AcidAntitubercular AgentsBacterial ProteinsMethylenetetrahydrofolate Reductase (NADPH2)methioninemethylenetetrahydrofolate reductaseMycobacterium tuberculosispara-aminosalicylic acidRv2172c

Identifiers

PMID34780266
PMCPMC8765232
OpenAlexW3214092526

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.